N. Zöllner
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
Papers in
-
- Metabolism and Genetic Disorders 20
- Nephrology 19
- Gout, Hyperuricemia, Uric Acid 16
- Journals
- Journal of Molecular Medicine (35 papers)Annals of Nutrition and Metabolism (11 papers)Advances in experimental medicine and biology (10 papers)Atherosclerosis (7 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (4 papers)
- Partner nations
- GermanyUnited StatesGreece
In The Last Decade
N. Zöllner
182 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Nephrology 194
- Clinical Biochemistry 153
- Endocrinology, Diabetes and Metabolism 331
- Nutrition and Dietetics 247
- Biochemistry 106
Countries citing papers authored by N. Zöllner
This map shows the geographic impact of N. Zöllner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Zöllner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Zöllner more than expected).
Fields of papers citing papers by N. Zöllner
This network shows the impact of papers produced by N. Zöllner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Zöllner. The network helps show where N. Zöllner may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Zöllner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 38 | |
| 2 | 1994 | 14 | |
| 3 | 1992 | 32 | |
| 4 | 1992 | 1 | |
| 5 | 1991 | 7 | |
| 6 | 1991 | 27 | |
| 7 | 1991 | 10 | |
| 8 | 1990 | 7 | |
| 9 | 1990 | 12 | |
| 10 | 1990 | 1 | |
| 11 | 1990 | 17 | |
| 12 | 1989 | 3 | |
| 13 | 1988 | 13 | |
| 14 | 1988 | 6 | |
| 15 | 1984 | 20 | |
| 16 | [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)]. | 1979 | 5 |
| 17 | [Manifestation of gout. Observations concerning the combined effects of nutrition and biochemical individuality]. | 1977 | 1 |
| 18 | 1977 | 3 | |
| 19 | [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate]. | 1976 | 1 |
| 20 | 1972 | 14 |
About N. Zöllner
N. Zöllner is a scholar working on Clinical Biochemistry, Nephrology, Endocrinology, Diabetes and Metabolism, Microbiology and Nutrition and Dietetics, having authored 207 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (21 papers), Metabolism and Genetic Disorders (20 papers), Biochemical and Molecular Research (18 papers), Gout, Hyperuricemia, Uric Acid (16 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers), Cancer, Lipids, and Metabolism (13 papers), Fatty Acid Research and Health (11 papers) and Diet, Metabolism, and Disease (11 papers). The work is most often cited by research in Nephrology (194 citations), Clinical Biochemistry (153 citations), Endocrinology, Diabetes and Metabolism (331 citations), Nutrition and Dietetics (247 citations) and Biochemistry (106 citations). N. Zöllner has collaborated with scholars based in Germany, United States and Greece. Frequent co-authors include G. Wolfram, O. Adam, H. Schuster, Wolfgang Gröbner, G Rauh, C. Keller, D. Pongratz, Hiroko Morisaki, Takayuki Morisaki and E W Holmes. Their work appears in journals such as Journal of Molecular Medicine, Annals of Nutrition and Metabolism, Advances in experimental medicine and biology, Atherosclerosis and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.